Plasma concentrations and pharmacokinetics of bupivacaine with and without adrenaline following caudal anaesthesia in infants

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Download / Buy Article:



The aim of this study was to determine whether the use of adrenaline 1/400 000 added to 0.25% bupivacaine significantly delays the systemic absorption of the drug from the caudal epidural space in young infants. Methods:

Fifteen infants less than 5 months of age undergoing minor lower abdominal procedures under a standardised general anaesthetic were randomised to receive a caudal block with either 0.25% plain bupivacaine 2.5 mg/kg (n=7) or bupivacaine 0.25% with 1/400 000 adrenaline (n=8). Blood samples were drawn at 30, 60, 90, 180, 240 and 360 min according to the infant’s weight and analysed for total and free bupivacaine concentrations using a gas chromatography-mass spectrometry (GC-MS) technique. Results:

The total CMAX and TMAX were comparable in both groups. The total bupivacaine concentration at t=360 min was significantly higher in the “adrenaline” group compared to the “plain” group, i.e. a median (range) 742 ng/ml (372–1423 ng/ml) vs. 400.5 ng/ml (114–446 ng/ml), P=0.0080. The median “apparent” terminal half-life (t½) was significantly longer in the “adrenaline” group (363 min; range 238–537 min) compared to the “plain” group (n=6) (165 min; range 104–264 min), P=0.0087. The free bupivacaine concentrations (n=3 in both groups) ranged between 13 ng/ml and 52 ng/ml, corresponding to a percentage of free bupivacaine between 1.3% and 6.7%. Conclusion:

The addition of 1/400.000 adrenaline prolongs the systemic absorption of caudally administered bupivacaine in infants less than 5 months of age.

Keywords: Local anesthetic: bupivacaine; anesthetic technique: caudal block; pharmacokinetics: systemic absorption, neonates and infants

Document Type: Research Article

Affiliations: 1: Directorate of Anaesthesia, The Royal Hospital for Sick Children, Yorkhill, Glasgow, and 2: Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow, Scotland, United Kingdom

Publication date: January 1, 2001

Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more